Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trialAngela Huttner, Veronica Gambillara Fonck, Germie van den Dobbelsteen et al.|The Lancet Infectious Diseases|2017Cited by 209